Rooibos Tea

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion inflammation skin

Research Overview

Across the abstracts provided, rooibos tea (Aspalathus linearis) research clusters into three main areas: (1) analytical chemistry and profiling of phenolic constituents, (2) mechanistic/preclinical health research focused on specific rooibos flavonoids and polyphenols, and (3) use of rooibos tea as a standardized plant substrate in ecological decomposition studies (TeaComposition). The analytical studies are particularly developed, emphasizing improved chromatographic methods (optimized RP-LC/HPLC-DAD and comprehensive 2D HILIC×RP-LC with MS) to resolve and quantify major and minor phenolics in fermented vs. unfermented rooibos, including identification/reporting of compounds such as aspalathin, orientin/isoorientin, PPAG, and newly described derivatives. In parallel, biomedical abstracts highlight targeted cellular assays (e.g., osteoblast-like Saos2 cells) and screening approaches relevant to metabolic disease pathways (e.g., URAT1 inhibition for hyperuricemia/gout risk), while social/behavioral work notes rooibos tea as one of several non-nutritive fluids introduced into infant feeding in certain informal work contexts.

The strongest evidence in this set supports (a) the feasibility and robustness of modern chromatographic platforms to characterize rooibos phenolic composition with high resolution and quantitative capability, and (b) biological activity of isolated rooibos flavonoids in controlled in vitro systems. Specifically, orientin and luteolin increased mineral content and osteoblast activity markers while reducing toxicity/inflammatory and bone-regulatory proteins in a human osteoblast cell line, providing mechanistic plausibility for bone-related effects but not direct clinical efficacy. Separately, the TeaComposition work provides strong evidence that, when rooibos is used as a standardized litter substrate, “litter quality” dominates early-stage decomposition variability globally, with climate effects emerging more clearly when aggregated at biome scale—this supports rooibos’ utility as a standardized ecological assay material rather than informing human health outcomes.

Key gaps are the translation from chemistry and cell-based findings to human-relevant outcomes and exposures. More research is needed to link quantified phenolic profiles (and differences between fermented/unfermented preparations) to bioavailability, metabolism, dose–response, and clinically meaningful endpoints in well-designed animal studies and randomized controlled trials (e.g., bone health, glycemic control/antidiabetic effects, and urate lowering via URAT1-related mechanisms). Additional work is also warranted on safety and appropriate use in vulnerable populations (e.g., infants), given qualitative evidence that rooibos tea may be used as a non-nutritive fluid in infant feeding under socioeconomic constraints. Finally, longer-term and experimentally controlled ecological studies are needed to extend early-stage decomposition findings to later stages and to disentangle interacting drivers over time.

1. What conditions has Rooibos Tea been studied for?

  • Type 2 diabetes / hyperglycemia and insulin resistance (preclinical): Green rooibos extract (GRE) and its polyphenol aspalathin were studied for glucose uptake and blood glucose effects.

  • Oxidative stress, stress resistance, and longevity under metabolic stress (preclinical): Rooibos extracts (green vs fermented/red) were studied in C. elegans under high-glucose and oxidative stress conditions.

  • Neurotoxicity models relevant to Parkinson’s disease (cell study): Isoorientin (a rooibos-derived flavone) was studied in a 6-OHDA-induced toxicity model in SH-SY5Y cells.

  • Bone health / osteoblast function (cell study): Rooibos flavonoids orientin and luteolin were studied in a human osteoblast-like cell line (Saos2) for mineralization-related outcomes.

  • Hyperuricemia/gout target (screening study context): A study screened plant extracts for URAT1 inhibition (a mechanism relevant to lowering serum urate). The provided abstract is truncated, so rooibos-specific results cannot be confirmed from the text shown.

  • Infant feeding practices (observational qualitative research): Rooibos tea appeared as a non-nutritive fluid given to infants when mothers returned to informal work (this is not a therapeutic study, but a public health context involving rooibos use).

  • Environmental/soil science (not human health): Rooibos tea bags were used as a standardized substrate to study litter decomposition globally (TeaComposition initiative).

2. Does it work in treating those conditions? Summarize the evidence.

  • Diabetes-related outcomes: Evidence is promising but preclinical. In vitro, GRE increased glucose uptake in L6 myotubes without insulin and promoted signaling linked to GLUT4 translocation (AMPK phosphorylation, and also Akt phosphorylation unlike isolated aspalathin). In pancreatic β-cell model RIN-5F cells, GRE suppressed AGEs-induced ROS. In vivo, subchronic feeding with GRE suppressed increases in fasting blood glucose in obese diabetic KK-A(y) mice. These results support antidiabetic potential, but they do not establish efficacy in humans.

  • Oxidative stress / longevity under stress: In C. elegans, rooibos extract extended lifespan in a high-glucose environment and reduced acute oxidative damage from juglone; green rooibos was more potent than red/fermented rooibos, plausibly due to higher aspalathin. Gene expression data suggested effects on stress/ageing pathways (including DAF-16/FOXO insulin-like signaling). This supports antioxidant/stress-resistance effects in a model organism, but not clinical treatment evidence.

  • Parkinson’s disease-relevant neuroprotection: Isoorientin reduced 6-OHDA-induced neurotoxicity in SH-SY5Y cells (reduced apoptosis markers and ROS; improved mitochondrial membrane potential) and induced antioxidant enzymes via Nrf2 nuclear translocation. Mechanistically, AMPK and PI3K/AKT inhibition and Nrf2 knockdown abrogated protection. This is mechanistic cell evidence only; it does not demonstrate clinical benefit in PD.

  • Bone health: In Saos2 osteoblast-like cells, orientin (multiple concentrations) and luteolin (5 µM) increased mineral content and alkaline phosphatase activity, with lower toxicity markers and reduced expression of inflammatory/regulatory proteins (e.g., TNF-α, IL-6, sclerostin). This supports a plausible bone-anabolic signal in vitro, but does not prove improved bone density or fracture outcomes in humans.

  • Hyperuricemia/gout: The abstract provided indicates URAT1 inhibition screening of plant extracts, but rooibos-specific outcomes are not included in the text shown; therefore, no conclusion can be drawn from these excerpts.

Overall: Across the provided abstracts, evidence for “treating” conditions is largely cell/animal-model based. Human clinical efficacy is not established in the excerpts provided.

3. What health benefits does it have?

  • Potential glycemic support (preclinical): GRE increased glucose uptake and promoted GLUT4 translocation-related signaling (AMPK and Akt) in muscle cells, reduced AGEs-related oxidative stress in β-cells, and improved fasting glucose trajectory in a diabetic mouse model.

  • Antioxidant and stress-resistance effects (preclinical): Rooibos extracts reduced oxidative damage and improved survival/lifespan under high-glucose and oxidative stress in C. elegans, with aspalathin implicated as a major contributor and green rooibos appearing more potent than fermented rooibos.

  • Neuroprotective antioxidant signaling (cell evidence): Isoorientin activated AMPK/AKT–Nrf2 signaling and increased antioxidant enzymes (e.g., HO-1, NQO1, Trx-1) while reducing oxidative stress and apoptosis in a toxin-induced neuronal cell model.

  • Bone-related cellular effects (cell evidence): Orientin and luteolin increased mineralization markers in osteoblast-like cells and reduced inflammatory/toxicity signals, consistent with a potential bone-supportive mechanism.

  • Low caffeine relevance (contextual): The bone-health abstract notes rooibos contains no caffeine, which is framed as potentially beneficial because caffeine can be detrimental to bone health in some contexts (this is a rationale statement, not direct clinical proof).

Important limitation: These benefits are primarily supported by mechanistic, cell-based, or animal/organism studies in the provided abstracts, not by human clinical trials.

4. Does it have any downsides or side effects?

  • Safety/side effects are not well characterized in the provided abstracts. The excerpts do not report adverse events in humans or systematic safety outcomes.

  • Infant feeding concern (public health context): In qualitative focus groups, some mothers reported giving infants “non-nutritive fluids like Rooibos tea” when returning to work. While not a toxicity finding, this raises a potential concern that rooibos tea could displace breastmilk/formula or appropriate nutrition/hydration practices in infants.

  • Cell study toxicity signals: In osteoblast-like cells, orientin/luteolin were associated with lower toxicity markers (LDH) under the study conditions, which is reassuring in vitro but does not establish real-world safety at supplemental doses.

Bottom line: From these abstracts alone, there is insufficient evidence to list specific, evidence-based side effects in humans; safety conclusions would require human studies and pharmacovigilance data not included here.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are provided in the abstracts.

  • No gene-variant (SNP) interactions reported: None of the excerpts link rooibos (or its compounds like aspalathin, orientin, isoorientin, luteolin) to outcomes stratified by human genotype.

  • Mechanistic pathways are described but not variant-specific: The neurotoxicity study implicates AMPK/AKT–Nrf2 signaling and antioxidant enzyme induction, and the C. elegans study implicates DAF-16/FOXO-related signaling; however, these do not translate into evidence that specific human genetic variants predict benefit or harm.

Conclusion: Based on the provided abstracts, there is no evidence to claim rooibos tea is beneficial or harmful for specific genetic variations.

References

  1. Early stage litter decomposition across biomes.
    Ika Djukic, Sebastian Kepfer-Rojas, Inger Kappel Schmidt, Klaus Steenberg Larsen, Claus Beier, Björn Berg, Kris Verheyen (2018) - The Science of the total environment
  2. Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway.
    Leslie A Nash, Philip J Sullivan, Sandra J Peters, Wendy E Ward (2015) - Molecular nutrition & food research
  3. Kinetic optimisation of the reversed phase liquid chromatographic separation of rooibos tea (Aspalathus linearis) phenolics on conventional high performance liquid chromatographic instrumentation.
    Theresa Beelders, Gunnar O Sigge, Elizabeth Joubert, Dalene de Beer, André de Villiers (2012) - Journal of chromatography. A
  4. Comprehensive two-dimensional liquid chromatographic analysis of rooibos (Aspalathus linearis) phenolics.
    Theresa Beelders, Kathithileni M Kalili, Elizabeth Joubert, Dalene de Beer, André de Villiers (2012) - Journal of separation science
  5. Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves.
    Yu Toyoda, Tappei Takada, Hiroki Saito, Hiroshi Hirata, Ami Ota-Kontani, Youichi Tsuchiya, Hiroshi Suzuki (2022) - Nutrients
  6. Attitudes and perceptions about breastfeeding among female and male informal workers in India and South Africa.
    C Horwood, A Surie, L Haskins, S Luthuli, R Hinton, A Chowdhury, N Rollins (2020) - BMC public health
  7. Impact of Cold versus Hot Brewing on the Phenolic Profile and Antioxidant Capacity of Rooibos (
    Elisabetta Damiani, Patricia Carloni, Gabriele Rocchetti, Biancamaria Senizza, Luca Tiano, Elizabeth Joubert, Dalene de Beer, Luigi Lucini (2019) - Antioxidants (Basel, Switzerland)
  8. Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-A(y) mice.
    Remi Kamakura, Myoung Jin Son, Dalene de Beer, Elizabeth Joubert, Yutaka Miura, Kazumi Yagasaki (2015) - Cytotechnology
  9. Ameliorative effect of aspalathin from rooibos (Aspalathus linearis) on acute oxidative stress in Caenorhabditis elegans.
    Wei Chen, Ikhwan Resmala Sudji, Erjia Wang, Elizabeth Joubert, Ben-Erik van Wyk, Michael Wink (2013) - Phytomedicine : international journal of phytotherapy and phytopharmacology
  10. Aspalathin and Other Rooibos Flavonoids Trapped α-Dicarbonyls and Inhibited Formation of Advanced Glycation End Products In Vitro.
    Katarzyna Bednarska, Izabela Fecka (2022) - International journal of molecular sciences
  11. Isoorientin exerts a protective effect against 6-OHDA-induced neurotoxicity by activating the AMPK/AKT/Nrf2 signalling pathway.
    Li Ma, Boxi Zhang, Jiahe Liu, Chunyu Qiao, Yuanyuan Liu, Shize Li, Hongming Lv (2020) - Food & function
  12. Lipid and protein stability and sensory evaluation of ostrich (Struthio camelus) droëwors with the addition of rooibos tea extract (Aspalathus linearis) as a natural antioxidant.
    Louwrens C Hoffman, Maxine Jones, Nina Muller, Elizabeth Joubert, Annalene Sadie (2014) - Meat science
  13. Tacrolimus and herbs interactions: a review.
    I Abushammala (2021) - Die Pharmazie
  14. Sensory Characteristics and Volatile Compounds of Herbal Teas and Mixtures of Bush Tea with Other Selected Herbal Teas of South Africa.
    Florence Malongane, Lyndy Joy McGaw, Legesse Kassa Debusho, Fhatuwani Nixwell Mudau (2020) - Foods (Basel, Switzerland)
  15. Rooibos tea (Aspalathus linearis) ameliorates the CCl4-induced injury to mitochondrial respiratory function and energy production in rat liver.
    Oľga Uličná, Oľga Vančová, Jarmila Kucharská, Pavol Janega, Iveta Waczulíková (2019) - General physiology and biophysics
  16. Estimated Contributions of Rooibos Tea to the Daily Manganese and Zinc Intakes Determined in Tea Leaves and Tea Infusions by Inductively Coupled Plasma-Mass Spectrometry.
    Nombuzo Mabuza, Henok H Kinfe, Taddese W Godeto, Abayneh A Ambushe (2021) - Biological trace element research
  17. Risk assessment of heavy metals in rooibos (Aspalathus linearis) tea consumed in South Africa.
    Oluwaseun Mary Areo, Patrick Berka Njobeh (2021) - Environmental science and pollution research international
  18. Green, Black and Rooibos Tea Inhibit Prostaglandin E2 Formation in Human Monocytes by Inhibiting Expression of Enzymes in the Prostaglandin E2 Pathway.
    Alexander Hedbrant, Ingrid Persson, Ann Erlandsson, Jonny Wijkander (2022) - Molecules (Basel, Switzerland)
  19. Analysis of variance of designed chromatographic data sets: The analysis of variance-target projection approach.
    Federico Marini, Dalene de Beer, Elizabeth Joubert, Beata Walczak (2015) - Journal of chromatography. A
  20. Rooibos (Aspalathus linearis) alters secretome trace amine profile of probiotic and commensal microbes in vitro.
    L Pretorius, A D Van Staden, T A Kellermann, N Henning, C Smith (2022) - Journal of ethnopharmacology


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!